These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10834612)

  • 41. Comparison of tolerance inducibility to class I or class II antigens between cyclophosphamide (CP)-induced tolerance and transfusion with donor cells: general effectiveness of CP-induced tolerance and difference of skin graft prolongation in each class I antigen-disparate combination.
    Tomita Y; Nomoto K
    Immunobiology; 1992 Nov; 186(3-4):282-91. PubMed ID: 1490733
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Induction of tolerance across major barriers using a two-step method with genetic analysis of tolerance induction.
    Mayumi H; Good RA
    Immunobiology; 1989 Mar; 179(1):86-108. PubMed ID: 2659501
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of transient treatment with FK506 in the early phase on cyclophosphamide-induced bone marrow chimerism and transplant tolerance across MHC barriers.
    Okayama J; Ko S; Kanehiro H; Kanokogi H; Nakajima Y
    J Surg Res; 2006 Jun; 133(2):61-8. PubMed ID: 16376943
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Distinct mechanisms for the induction and maintenance of allograft tolerance with CTLA4-Fc treatment.
    Tran HM; Nickerson PW; Restifo AC; Ivis-Woodward MA; Patel A; Allen RD; Strom TB; O'Connell PJ
    J Immunol; 1997 Sep; 159(5):2232-9. PubMed ID: 9278311
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Syngeneic bone marrow expressing a single donor class I MHC molecule permits acceptance of a fully allogeneic cardiac allograft.
    Wong W; Morris PJ; Wood KJ
    Transplantation; 1996 Nov; 62(10):1462-8. PubMed ID: 8958273
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Drug-induced tolerance to allografts in mice. X. Augmentation of split tolerance in murine combinations disparate at both H-2 and non-H-2 antigens by the use of spleen cells from donors preimmunized with recipient antigens.
    Mayumi H; Himeno K; Tokuda N; Fan JL; Nomoto K
    Immunobiology; 1987 May; 174(3):274-91. PubMed ID: 3305319
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evidence that the continued presence of the organ graft and not peripheral donor microchimerism is essential for maintenance of tolerance to alloantigen in vivo in anti-CD4 treated recipients.
    Hamano K; Rawsthorne MA; Bushell AR; Morris PJ; Wood KJ
    Transplantation; 1996 Sep; 62(6):856-60. PubMed ID: 8824489
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immune tolerance induced by donor antigen and cyclophosphamide in rat fetal small bowel transplantation.
    Nakao M; Taguchi T; Ogita K; Nishimoto Y; Suita S
    Fukuoka Igaku Zasshi; 2005 Feb; 96(2):49-57. PubMed ID: 15852663
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells.
    Casiraghi F; Azzollini N; Cassis P; Imberti B; Morigi M; Cugini D; Cavinato RA; Todeschini M; Solini S; Sonzogni A; Perico N; Remuzzi G; Noris M
    J Immunol; 2008 Sep; 181(6):3933-46. PubMed ID: 18768848
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tolerance in a rat cardiac allograft model after short-term treatment with LF 08-0299. Absence of clonal deletion and evidence of CD4+ suppressor cells.
    Andoins C; de Fornel D; Annat J; Dutartre P
    Transplantation; 1996 Dec; 62(11):1543-9. PubMed ID: 8970605
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevention of induction of unresponsiveness to class I antigens by veto activity of donor marrow in cylophosphamide-treated mice.
    Tomita Y; Nomoto K
    Transplantation; 1993 Dec; 56(6):1473-80. PubMed ID: 8279022
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft.
    Donckier V; Troisi R; Toungouz M; Colle I; Van Vlierberghe H; Jacquy C; Martiat P; Stordeur P; Zhou L; Boon N; Lambermont M; Schandené L; Van Laethem JL; Noens L; Gelin M; de Hemptinne B; Goldman M
    Transpl Immunol; 2004; 13(2):139-46. PubMed ID: 15380544
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Durability of donor-specific and organ-specific heart transplant tolerance induced by intrathymic pretreatment with allogeneic spleen cells.
    Shen Z; Mohiuddin M; Goldstein C; Yokoyama H; DiSesa VJ
    J Thorac Cardiovasc Surg; 1996 Feb; 111(2):429-31. PubMed ID: 8583817
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intrathymic injection of donor alloantigens induces donor-specific vascularized allograft tolerance without immunosuppression.
    Goss JA; Nakafusa Y; Flye MW
    Ann Surg; 1992 Oct; 216(4):409-14; discussion 414-6. PubMed ID: 1417190
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induction of donor specific transplantation tolerance to cardiac allografts following treatment with nondepleting (RIB 5/2) or depleting (OX-38) anti-CD4 mAb plus intrathymic or intravenous donor alloantigen.
    Arima T; Lehmann M; Flye MW
    Transplantation; 1997 Jan; 63(2):284-92. PubMed ID: 9020332
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Indefinite survival of skin allografts in adult thymectomized, antilymphocyte serum-treated mice given bone marrow and thymus grafts of donor origin: tolerance induction by donor bone marrow and thymus.
    Fukuzaki T; Hancock WW; Monaco AP; Maki T
    Transplantation; 1998 Apr; 65(8):1036-43. PubMed ID: 9583862
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunosuppression to cardiac allografts and soluble antigens by anti-vascular cellular adhesion molecule-1 and anti-very late antigen-4 monoclonal antibodies.
    Isobe M; Suzuki J; Yagita H; Okumura K; Yamazaki S; Nagai R; Yazaki Y; Sekiguchi M
    J Immunol; 1994 Dec; 153(12):5810-8. PubMed ID: 7527450
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regulatory roles of NKT cells in the induction and maintenance of cyclophosphamide-induced tolerance.
    Iwai T; Tomita Y; Okano S; Shimizu I; Yasunami Y; Kajiwara T; Yoshikai Y; Taniguchi M; Nomoto K; Yasui H
    J Immunol; 2006 Dec; 177(12):8400-9. PubMed ID: 17142737
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunologic mechanisms in tolerance produced in mice with nonradiation-based lymphoablation and donor-specific bone marrow.
    Hale DA; Gottschalk R; Umemura A; Maki T; Monaco AP
    Transplantation; 2002 Aug; 74(4):477-84. PubMed ID: 12352905
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mixed allogeneic chimerism achieved by lethal and nonlethal conditioning approaches induces donor-specific tolerance to simultaneous islet allografts.
    Li H; Colson YL; Ildstad ST
    Transplantation; 1995 Sep; 60(6):523-9. PubMed ID: 7570945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.